Skip to main content

LION Releases genomeScout 1.0

NEW YORK, Sept 7 - LION bioscience (Nasdaq: LEON) said on Thursday it had released genomeSCOUT 1.0, a software package for genome comparison and analysis.

genomeSCOUT uses comparative genomics to help researchers gain information about the   functionality of as well as the differences between the growing number of sequenced genomes. The software also allows users to discover unique genes in any set of organisms, and to assign functions to genes and to compare metabolic pathways in different organisms.

Such findings could lead to the identification of microbial drug targets and in the development of vaccines.

genomeSCOUT is based on LION’s SRS Data Integration System, which supports more than 400 public and private databases and applications.

Based in Heidelberg, Germany LION bioscience develops R&D data analysis and information management systems for the life science sector. The company has alliances with such companies as Aventis (NYSE: AVE), Bayer, Celera (NYSE: CRA) and Sumitomo Pharmaceuticals.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.